Annexin A11 mutations are associated with nuclear envelope dysfunction in vivo and in human tissue.

amyotrophic lateral sclerosis annexin A11 lamin B2 nuclear envelope

Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
11 Jul 2024
Historique:
received: 24 11 2023
revised: 04 05 2024
accepted: 20 05 2024
medline: 11 7 2024
pubmed: 11 7 2024
entrez: 11 7 2024
Statut: aheadofprint

Résumé

Annexin A11 mutations are a rare cause of amyotrophic lateral sclerosis (ALS), wherein replicated protein variants P36R, G38R, D40G and D40Y are located in a small-alpha helix within the long, disordered N-terminus. To elucidate disease mechanisms, we characterised the phenotypes induced by a genetic loss of function (LoF) and by misexpression of G38R and D40G in vivo. Loss of Annexin A11 results in a low-penetrant behavioural phenotype and aberrant axonal morphology in zebrafish homozygous knockout larvae, which is rescued by human WT Annexin A11. Both Annexin A11 knockout/down and ALS variants trigger nuclear dysfunction characterised by Lamin B2 mis-localisation. The Lamin B2 signature also presented in anterior horn, spinal cord neurons from post-mortem ALS+/-FTD patient tissue possessing G38R and D40G protein variants. These findings suggest mutant Annexin A11 acts as a dominant negative, revealing a potential early nucleopathy highlighting nuclear envelope abnormalities preceding behavioural abnormality in animal models.

Identifiants

pubmed: 38989900
pii: 7711014
doi: 10.1093/brain/awae226
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the Guarantors of Brain.

Auteurs

Valentina Marchica (V)

Department of Basic and Clinical Neuroscience, Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 1 Camberwell, SE5 9NU London, UK.
Centre for Developmental Neurobiology and MRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, Guy's Campus, King's College London, London SE1 1UL, UK.

Luca Biasetti (L)

Department of Basic and Clinical Neuroscience, Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 1 Camberwell, SE5 9NU London, UK.

Jodi Barnard (J)

Department of Basic and Clinical Neuroscience, Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 1 Camberwell, SE5 9NU London, UK.

Shujing Li (S)

Department of Basic and Clinical Neuroscience, Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 1 Camberwell, SE5 9NU London, UK.

Nikolas Nikolaou (N)

Department of Life Sciences, University of Bath, Claverton Down, Bath BA2 7AY, UK.

Matthew P Frosch (MP)

Mass General Institute for Neurodegenerative Diseases, B114-2700, Charlestown, MA 02129, USA.
C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital, Boston, MA 02114, USA.

Diane E Lucente (DE)

Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.

Mark Eldaief (M)

Mass General Institute for Neurodegenerative Diseases, B114-2700, Charlestown, MA 02129, USA.

Andrew King (A)

Department of Basic and Clinical Neuroscience, Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 1 Camberwell, SE5 9NU London, UK.
London Neurodegenerative Diseases Brain Bank, SGDP Centre, PO65, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London, SE5 8AF, UK.

Manolis Fanto (M)

Department of Basic and Clinical Neuroscience, Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 1 Camberwell, SE5 9NU London, UK.

Claire Troakes (C)

Department of Basic and Clinical Neuroscience, Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 1 Camberwell, SE5 9NU London, UK.
London Neurodegenerative Diseases Brain Bank, SGDP Centre, PO65, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London, SE5 8AF, UK.

Corinne Houart (C)

Centre for Developmental Neurobiology and MRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, Guy's Campus, King's College London, London SE1 1UL, UK.

Bradley N Smith (BN)

Department of Basic and Clinical Neuroscience, Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 1 Camberwell, SE5 9NU London, UK.
Centre for Developmental Neurobiology and MRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, Guy's Campus, King's College London, London SE1 1UL, UK.

Classifications MeSH